Protocol to extract and sort GFP-tagged nuclei from lung adenocarcinoma tissue in genetically engineered mouse models
Here, we present a protocol to isolate GFP-positive nuclei from whole lung tumor tissue from a genetically engineered mouse model (GEMM) for downstream analysis. First, we outline the procedure for the isolation of fixed GFP-positive nuclei for utilization in chromatin immunoprecipitation followed by sequencing (ChIP-seq) assay. We also describe the sorting of unfixed nuclei for whole-genome methylation analysis. This nuclei collection methodology can be adapted for the retrieval of other fluorescently tagged nuclei and/or for use in other downstream analysis. For complete details on the use and execution of this protocol, please refer to Gillis et al.<sup>1</sup>.
Authors
- Katherine L. Gillis
- Eric L. Snyder (ORCID: https://orcid.org/0000-0003-3591-3195)
- Walter A. Orellana (ORCID: https://orcid.org/0000-0003-4109-021X)
Institutions
- Huntsman Cancer Institute (US)
Publication Details
- Journal
- STAR Protocols
- Published
- 2026-01-08
- DOI
- https://doi.org/10.1016/j.xpro.2025.104328
- Primary Topic
- Lung Cancer Treatments and Mutations
- Type
- article
- Field-Weighted Citation Impact
- 0.00